Message from the President
Continual Innovation to Maximize Enterprise and Shareholder Values.
The MEDIPAL Group is currently implementing the 2027 MEDIPAL Medium-Term Vision.
We feel that this “vision” is an expression of our hopes and dreams.
My approach to corporate management is to create a company where these dreams come true, and expand to become ever larger.
Our aim is for a company that is bright, energetic, visionary, a company that continually creates new value in distribution, and contributes to the health of people and advancement of society.
MEDIPAL Group is constantly innovating.
Through these innovations we aim to achieve long-term growth in the pharmaceutical, health, and beauty sectors, further enhance our enterprise value, and maximize value for shareholders.
I would like to express my appreciation to all our shareholders and investors for their understanding and support, and to join us in the anticipation of realizing dreams through innovation.
Shuichi Watanabe
Representative Director, President and CEO